Thu, March 28, 2024
Wed, March 27, 2024
Tue, March 26, 2024

Arthur He Maintained (BCAB) at Strong Buy with Decreased Target to $7 on, Mar 27th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-7-on-mar-27th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Arthur He of HC Wainwright & Co., Maintained "BioAtla, Inc." (BCAB) at Strong Buy with Decreased Target from $10 to $7 on, Mar 27th, 2024.

Arthur has made no other calls on BCAB in the last 4 months.



There is 1 other peer that has a rating on BCAB. Out of the 1 peers that are also analyzing BCAB, 0 agree with Arthur's Rating of Hold.



This is the rating of the analyst that currently disagrees with Arthur


  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Tuesday, December 5th, 2023

Publication Contributing Sources